Investor Resources

Resources for investors and interested parties

Delta4 is committed to creating revolutionary treatments to benefit patients with rare and complex diseases. That’s why we’ve made it our mission to use the latest technology to pursue drug discovery and drug repositioning.

Here you’ll find resources, such as videos, case studies, and detailed explanations, to help investors and interested parties better understand our approach to AI-driven drug discovery. Our team’s mission is to make sure that everyone has the information they need to understand the work we’re doing at Delta4.

Press Release

For the latest press releases and important industry events, check here to stay current with what we’re up to.

Delta team

Delta4 joins the EU-funded COST action PerMediK (Personalized medicine in chronic kidney disease: improved outcome based on Big Data)

September 24, 2023 No Comments

The scientific goal of PerMediK is to foster development toward personalized medicine in chronic kidney disease (CKD), based on multidimensional ...

scientist reviewing data on computer

Delta4 Announces Prof. Doron Lancet To Join Scientific Advisory Board

March 6, 2023 No Comments

VIENNA, Austria, March 6th, 2023 — Delta4, a digital drug discovery company focusing on the identification of new indications for ...

Kurt Herpel, CEO of Delta4, and Revital Rattenbach, CEO of 4P-Pharma, celebrating the signature of a partnership agreement between Delta4 and 4P-Pharma in Paris (France).

4P-Pharma And Delta4 Join Forces To Find And Develop Treatments For A Rare Autoimmune Chronic Liver Disease

June 1, 2022 No Comments

Paris (France) and Vienna (Austria), 31st May 2022 – 4P-Pharma, a French clinical-stage biotechnology company, and Delta4, an Austrian digital ...

Media

Watch our videos to find out more about us and what we do.

Get Involved

Learn how you can contribute to the exciting work happening at Delta4

Careers

Forging the innovative treatments of the future requires brilliant minds and we’re always on the lookout for talent.

Investors

Contact us to find out more about how you can invest with us and be a part of pioneering the next successful treatment.

Medical Community

Learn how you can partner with us and combine our technology with your knowledge to develop treatments faster.

Our Partners & Clients

It’s an honor and a privilege to be working with the best of the best!

Top Pharma Germany

Top Pharma Scandinavia

Proud Member of Scientist.com

Streamlining Transparency and Cooperation

Scientist.com provides a unique platform where researchers and suppliers can both find each other and work together more easily. They provide a collaboration framework to streamline the typically long and tedious process of defining the terms and conditions of an agreement.
Members can work together smoothly and effortlessly by agreeing to the rules of the platform. The result is that together we can achieve the results we need faster.

“Delta4’s AI-Powered Hyper-C Platform Uncovers New Drug Indications, Expanding Treatment Potential for Iguratimod” – As Featured on Scientist.com

Are you a member of Scientist.com? View Our Profile